| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.88e-09 | 100 | 26 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 3.66e-09 | 459 | 26 | 9 | GO:0005216 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 5.31e-09 | 17 | 26 | 4 | GO:0022848 | |
| GeneOntologyMolecularFunction | channel activity | 1.18e-08 | 525 | 26 | 9 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 1.20e-08 | 526 | 26 | 9 | GO:0022803 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | MTNR1B CMKLR1 HTR2A GPR22 ADGRE1 SSTR2 CHRNA9 SSTR4 GPR158 CHRNA4 CHRNB2 CHRNB4 | 3.53e-08 | 1353 | 26 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | gated channel activity | 1.72e-07 | 334 | 26 | 7 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.06e-07 | 343 | 26 | 7 | GO:0005261 | |
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 2.69e-07 | 43 | 26 | 4 | GO:0005231 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.99e-07 | 793 | 26 | 9 | GO:0015075 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 5.56e-07 | 13 | 26 | 3 | GO:0042166 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 8.51e-07 | 57 | 26 | 4 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.05e-06 | 60 | 26 | 4 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | TRPV6 CLCN1 CHRNA9 SLC16A4 KCNC1 TRPV5 CHRNA4 CHRNB2 CHRNB4 CFTR | 1.11e-06 | 1180 | 26 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.45e-06 | 65 | 26 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.45e-06 | 65 | 26 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | transporter activity | TRPV6 CLCN1 CHRNA9 SLC16A4 KCNC1 TRPV5 CHRNA4 CHRNB2 CHRNB4 CFTR | 2.48e-06 | 1289 | 26 | 10 | GO:0005215 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.58e-06 | 75 | 26 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.86e-06 | 77 | 26 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 3.41e-06 | 23 | 26 | 3 | GO:0015464 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.47e-06 | 193 | 26 | 5 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.94e-06 | 197 | 26 | 5 | GO:0022834 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 1.10e-05 | 884 | 26 | 8 | GO:0004930 | |
| GeneOntologyMolecularFunction | somatostatin receptor activity | 1.63e-05 | 5 | 26 | 2 | GO:0004994 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.65e-05 | 664 | 26 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.07e-05 | 140 | 26 | 4 | GO:0099094 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 3.52e-04 | 758 | 26 | 6 | GO:0015318 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.14e-04 | 129 | 26 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 9.70e-04 | 151 | 26 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activator activity | 9.99e-04 | 36 | 26 | 2 | GO:0030296 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 1.06e-03 | 37 | 26 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | quaternary ammonium group binding | 1.63e-03 | 46 | 26 | 2 | GO:0050997 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 2.16e-03 | 53 | 26 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 2.89e-03 | 465 | 26 | 4 | GO:0046873 | |
| GeneOntologyMolecularFunction | chloride channel activity | 5.57e-03 | 86 | 26 | 2 | GO:0005254 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 7.90e-03 | 103 | 26 | 2 | GO:0005253 | |
| GeneOntologyMolecularFunction | peptide binding | 7.93e-03 | 318 | 26 | 3 | GO:0042277 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.31e-03 | 627 | 26 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.11e-02 | 123 | 26 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.15e-02 | 125 | 26 | 2 | GO:0015108 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.29e-02 | 133 | 26 | 2 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.42e-02 | 140 | 26 | 2 | GO:0001653 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 1.60e-02 | 149 | 26 | 2 | GO:0030295 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.64e-02 | 151 | 26 | 2 | GO:0008509 | |
| GeneOntologyMolecularFunction | kinase activator activity | 1.81e-02 | 159 | 26 | 2 | GO:0019209 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.07e-02 | 171 | 26 | 2 | GO:0015103 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.33e-02 | 182 | 26 | 2 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.37e-02 | 184 | 26 | 2 | GO:0022832 | |
| GeneOntologyBiologicalProcess | regulation of secretion | MTNR1B TRPV6 EFNA5 HTR2A SSTR4 GPR158 CHRNA4 CHRNB2 CHRNB4 CFTR | 2.23e-08 | 801 | 26 | 10 | GO:0051046 |
| GeneOntologyBiologicalProcess | signal release | 5.83e-08 | 653 | 26 | 9 | GO:0023061 | |
| GeneOntologyBiologicalProcess | action potential | 1.56e-07 | 201 | 26 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 1.69e-07 | 740 | 26 | 9 | GO:1903530 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.59e-07 | 112 | 26 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 2.81e-07 | 559 | 26 | 8 | GO:0042391 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 2.91e-07 | 11 | 26 | 3 | GO:0035095 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.81e-07 | 121 | 26 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | TRPV6 CLCN1 HTR2A CHRNA9 KCNC1 TRPV5 CHRNA4 CHRNB2 CHRNB4 CFTR | 4.91e-07 | 1115 | 26 | 10 | GO:0034220 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 9.86e-07 | 61 | 26 | 4 | GO:0007187 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.12e-06 | 63 | 26 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | secretion | MTNR1B TRPV6 EFNA5 HTR2A SSTR4 GPR158 CHRNA4 CHRNB2 CHRNB4 CFTR | 1.13e-06 | 1221 | 26 | 10 | GO:0046903 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | TRPV6 CLCN1 HTR2A CHRNA9 KCNC1 TRPV5 CHRNA4 CHRNB2 CHRNB4 CFTR | 3.30e-06 | 1374 | 26 | 10 | GO:0006811 |
| GeneOntologyBiologicalProcess | secretion by cell | 3.52e-06 | 1064 | 26 | 9 | GO:0032940 | |
| GeneOntologyBiologicalProcess | synaptic transmission involved in micturition | 4.58e-06 | 3 | 26 | 2 | GO:0060084 | |
| GeneOntologyBiologicalProcess | adult behavior | 4.89e-06 | 203 | 26 | 5 | GO:0030534 | |
| GeneOntologyBiologicalProcess | regulation of transmission of nerve impulse | 5.70e-06 | 28 | 26 | 3 | GO:0051969 | |
| GeneOntologyBiologicalProcess | export from cell | 6.79e-06 | 1153 | 26 | 9 | GO:0140352 | |
| GeneOntologyBiologicalProcess | sensory perception of pain | 8.70e-06 | 105 | 26 | 4 | GO:0019233 | |
| GeneOntologyBiologicalProcess | regulation of dopamine secretion | 1.04e-05 | 34 | 26 | 3 | GO:0014059 | |
| GeneOntologyBiologicalProcess | dopamine secretion | 1.84e-05 | 41 | 26 | 3 | GO:0014046 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 2.02e-05 | 130 | 26 | 4 | GO:0060079 | |
| GeneOntologyBiologicalProcess | metal ion transport | 2.12e-05 | 1000 | 26 | 8 | GO:0030001 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 2.21e-05 | 133 | 26 | 4 | GO:0006939 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 2.28e-05 | 44 | 26 | 3 | GO:0007271 | |
| GeneOntologyBiologicalProcess | somatostatin receptor signaling pathway | 2.28e-05 | 6 | 26 | 2 | GO:0038169 | |
| GeneOntologyBiologicalProcess | somatostatin signaling pathway | 2.28e-05 | 6 | 26 | 2 | GO:0038170 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 3.28e-05 | 147 | 26 | 4 | GO:0099565 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 3.32e-05 | 509 | 26 | 6 | GO:0006816 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 3.56e-05 | 51 | 26 | 3 | GO:0095500 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 3.99e-05 | 53 | 26 | 3 | GO:1905145 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 4.72e-05 | 56 | 26 | 3 | GO:1905144 | |
| GeneOntologyBiologicalProcess | dopamine transport | 4.97e-05 | 57 | 26 | 3 | GO:0015872 | |
| GeneOntologyBiologicalProcess | response to nicotine | 5.24e-05 | 58 | 26 | 3 | GO:0035094 | |
| GeneOntologyBiologicalProcess | negative regulation of transmission of nerve impulse | 5.47e-05 | 9 | 26 | 2 | GO:0051970 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | 6.03e-05 | 1157 | 26 | 8 | GO:0006812 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 7.22e-05 | 180 | 26 | 4 | GO:0060078 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 8.07e-05 | 67 | 26 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 8.07e-05 | 67 | 26 | 3 | GO:0050433 | |
| GeneOntologyBiologicalProcess | micturition | 8.35e-05 | 11 | 26 | 2 | GO:0060073 | |
| GeneOntologyBiologicalProcess | behavior | 8.76e-05 | 891 | 26 | 7 | GO:0007610 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 8.82e-05 | 69 | 26 | 3 | GO:0098926 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 1.15e-04 | 931 | 26 | 7 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 1.15e-04 | 931 | 26 | 7 | GO:0007268 | |
| GeneOntologyBiologicalProcess | positive regulation of transmission of nerve impulse | 1.18e-04 | 13 | 26 | 2 | GO:0051971 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 1.22e-04 | 939 | 26 | 7 | GO:0099537 | |
| GeneOntologyBiologicalProcess | muscle contraction | 1.26e-04 | 400 | 26 | 5 | GO:0006936 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 1.32e-04 | 79 | 26 | 3 | GO:0050432 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 1.55e-04 | 976 | 26 | 7 | GO:0099536 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle, non-REM sleep | 1.59e-04 | 15 | 26 | 2 | GO:0045188 | |
| GeneOntologyBiologicalProcess | regulation of neuronal action potential | 1.59e-04 | 15 | 26 | 2 | GO:0098908 | |
| GeneOntologyBiologicalProcess | cognition | 1.63e-04 | 423 | 26 | 5 | GO:0050890 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 1.68e-04 | 224 | 26 | 4 | GO:0007204 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, non-REM sleep | 1.81e-04 | 16 | 26 | 2 | GO:0042748 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | 2.00e-04 | 1017 | 26 | 7 | GO:0098660 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 2.23e-04 | 1395 | 26 | 8 | GO:0007186 | |
| GeneOntologyBiologicalProcess | cellular response to forskolin | 2.31e-04 | 18 | 26 | 2 | GO:1904322 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 2.35e-04 | 96 | 26 | 3 | GO:0051937 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 2.40e-04 | 1048 | 26 | 7 | GO:0014070 | |
| GeneOntologyBiologicalProcess | response to forskolin | 2.58e-04 | 19 | 26 | 2 | GO:1904321 | |
| GeneOntologyBiologicalProcess | optic nerve development | 3.48e-04 | 22 | 26 | 2 | GO:0021554 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 3.80e-04 | 113 | 26 | 3 | GO:0051262 | |
| GeneOntologyBiologicalProcess | monoamine transport | 4.10e-04 | 116 | 26 | 3 | GO:0015844 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 4.14e-04 | 284 | 26 | 4 | GO:0007626 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system process | 4.15e-04 | 24 | 26 | 2 | GO:0031645 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 5.10e-04 | 125 | 26 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | muscle system process | 5.34e-04 | 547 | 26 | 5 | GO:0003012 | |
| GeneOntologyBiologicalProcess | amine transport | 6.66e-04 | 137 | 26 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle, sleep | 6.95e-04 | 31 | 26 | 2 | GO:0045187 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, sleep | 7.88e-04 | 33 | 26 | 2 | GO:0050802 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | 8.37e-04 | 922 | 26 | 6 | GO:0098662 | |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 8.42e-04 | 605 | 26 | 5 | GO:0071407 | |
| GeneOntologyBiologicalProcess | renal system process | 8.50e-04 | 149 | 26 | 3 | GO:0003014 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle | 8.86e-04 | 35 | 26 | 2 | GO:0042749 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | 9.36e-04 | 942 | 26 | 6 | GO:0098655 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle process | 9.38e-04 | 36 | 26 | 2 | GO:0022410 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 9.38e-04 | 36 | 26 | 2 | GO:0007274 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 9.86e-04 | 358 | 26 | 4 | GO:0015850 | |
| GeneOntologyBiologicalProcess | excretion | 9.90e-04 | 37 | 26 | 2 | GO:0007588 | |
| GeneOntologyBiologicalProcess | response to auditory stimulus | 9.90e-04 | 37 | 26 | 2 | GO:0010996 | |
| GeneOntologyBiologicalProcess | sleep | 1.16e-03 | 40 | 26 | 2 | GO:0030431 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 1.27e-03 | 663 | 26 | 5 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 1.28e-03 | 664 | 26 | 5 | GO:0099177 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle | 1.34e-03 | 43 | 26 | 2 | GO:0042745 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 1.35e-03 | 175 | 26 | 3 | GO:0031644 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 1.38e-03 | 392 | 26 | 4 | GO:0070588 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.46e-03 | 684 | 26 | 5 | GO:0010817 | |
| GeneOntologyBiologicalProcess | memory | 1.54e-03 | 183 | 26 | 3 | GO:0007613 | |
| GeneOntologyBiologicalProcess | response to hormone | 1.58e-03 | 1042 | 26 | 6 | GO:0009725 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.66e-03 | 48 | 26 | 2 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.66e-03 | 48 | 26 | 2 | GO:1902656 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | 1.68e-03 | 1450 | 26 | 7 | GO:1901701 | |
| GeneOntologyBiologicalProcess | hormone secretion | 1.78e-03 | 420 | 26 | 4 | GO:0046879 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 1.91e-03 | 727 | 26 | 5 | GO:0032870 | |
| GeneOntologyBiologicalProcess | hormone transport | 1.97e-03 | 432 | 26 | 4 | GO:0009914 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.61e-10 | 378 | 27 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 6.67e-09 | 18 | 27 | 4 | GO:0005892 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.13e-08 | 523 | 27 | 9 | GO:1902495 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.59e-08 | 22 | 27 | 4 | GO:0098981 | |
| GeneOntologyCellularComponent | transporter complex | 1.74e-08 | 550 | 27 | 9 | GO:1990351 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.18e-07 | 405 | 27 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 5.31e-06 | 201 | 27 | 5 | GO:0099634 | |
| GeneOntologyCellularComponent | synaptic membrane | 6.92e-06 | 583 | 27 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.51e-05 | 277 | 27 | 5 | GO:0042734 | |
| GeneOntologyCellularComponent | membrane protein complex | 6.98e-05 | 1498 | 27 | 9 | GO:0098796 | |
| GeneOntologyCellularComponent | postsynapse | 2.40e-04 | 1018 | 27 | 7 | GO:0098794 | |
| GeneOntologyCellularComponent | dopaminergic synapse | 3.65e-04 | 22 | 27 | 2 | GO:0098691 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 4.12e-04 | 503 | 27 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | receptor complex | 7.93e-04 | 581 | 27 | 5 | GO:0043235 | |
| GeneOntologyCellularComponent | plasma membrane raft | 8.81e-04 | 147 | 27 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 1.00e-03 | 350 | 27 | 4 | GO:0098802 | |
| GeneOntologyCellularComponent | chloride channel complex | 2.45e-03 | 57 | 27 | 2 | GO:0034707 | |
| GeneOntologyCellularComponent | cell surface | 2.51e-03 | 1111 | 27 | 6 | GO:0009986 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.99e-03 | 785 | 27 | 5 | GO:0098797 | |
| GeneOntologyCellularComponent | cation channel complex | 3.36e-03 | 235 | 27 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.99e-03 | 73 | 27 | 2 | GO:0034704 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.19e-03 | 519 | 27 | 4 | GO:0009897 | |
| GeneOntologyCellularComponent | side of membrane | 4.76e-03 | 875 | 27 | 5 | GO:0098552 | |
| GeneOntologyCellularComponent | presynapse | 5.02e-03 | 886 | 27 | 5 | GO:0098793 | |
| GeneOntologyCellularComponent | caveola | 8.99e-03 | 111 | 27 | 2 | GO:0005901 | |
| HumanPheno | Focal hyperkinetic seizure | 8.85e-05 | 7 | 11 | 2 | HP:0011174 | |
| HumanPheno | Somnambulism | 8.85e-05 | 7 | 11 | 2 | HP:0025236 | |
| HumanPheno | Orthokeratotic hyperkeratosis | 8.85e-05 | 7 | 11 | 2 | HP:0025080 | |
| HumanPheno | Confusional arousal | 1.51e-04 | 9 | 11 | 2 | HP:0025237 | |
| HumanPheno | Increased theta frequency activity in EEG | 2.31e-04 | 11 | 11 | 2 | HP:0031535 | |
| MousePheno | abnormal anxiety-related response | CHST10 EFNA5 CLCN1 HTR2A SSTR2 KCNC1 DSG1 GPR158 CHRNA4 CHRNB2 | 2.57e-07 | 740 | 25 | 10 | MP:0001362 |
| MousePheno | abnormal fear/anxiety-related behavior | CHST10 EFNA5 CLCN1 HTR2A SSTR2 KCNC1 DSG1 GPR158 CHRNA4 CHRNB2 | 1.89e-06 | 919 | 25 | 10 | MP:0002065 |
| MousePheno | abnormal behavioral response to nicotine | 9.20e-06 | 3 | 25 | 2 | MP:0020160 | |
| MousePheno | decreased anxiety-related response | 1.02e-05 | 452 | 25 | 7 | MP:0001364 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 1.84e-05 | 4 | 25 | 2 | MP:0009475 | |
| MousePheno | abnormal small intestine crypts of Lieberkuhn morphology | 3.77e-05 | 37 | 25 | 3 | MP:0004841 | |
| MousePheno | abnormal synaptic transmission | MTNR1B CHST10 CLCN1 SSTR2 CHRNA9 GPR158 CHRNA4 CHRNB2 PTDSS1 | 5.79e-05 | 1070 | 25 | 9 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | MTNR1B CHST10 CLCN1 SSTR2 CHRNA9 GPR158 CHRNA4 CHRNB2 PTDSS1 | 6.05e-05 | 1076 | 25 | 9 | MP:0021009 |
| MousePheno | decreased Paneth cell number | 1.10e-04 | 9 | 25 | 2 | MP:0013486 | |
| MousePheno | abnormal Paneth cell number | 2.00e-04 | 12 | 25 | 2 | MP:0013484 | |
| MousePheno | abnormal CNS synaptic transmission | 2.17e-04 | 985 | 25 | 8 | MP:0002206 | |
| MousePheno | decreased chemically-elicited antinociception | 5.15e-04 | 19 | 25 | 2 | MP:0001982 | |
| MousePheno | abnormal Paneth cell morphology | 5.72e-04 | 20 | 25 | 2 | MP:0004843 | |
| MousePheno | abnormal vertical activity | 9.43e-04 | 439 | 25 | 5 | MP:0020167 | |
| MousePheno | abnormal alveolar macrophage morphology | 1.05e-03 | 27 | 25 | 2 | MP:0008245 | |
| MousePheno | abnormal crypts of Lieberkuhn morphology | 1.18e-03 | 118 | 25 | 3 | MP:0000490 | |
| MousePheno | abnormal pain threshold | 1.20e-03 | 267 | 25 | 4 | MP:0001970 | |
| MousePheno | abnormal chemically-elicited antinociception | 1.21e-03 | 29 | 25 | 2 | MP:0001980 | |
| MousePheno | abnormal mononuclear phagocyte morphology | 1.25e-03 | 705 | 25 | 6 | MP:0008248 | |
| MousePheno | abnormal myeloid leukocyte morphology | 1.34e-03 | 1292 | 25 | 8 | MP:0008250 | |
| MousePheno | abnormal uterus weight | 1.47e-03 | 32 | 25 | 2 | MP:0004903 | |
| MousePheno | abnormal phagocyte morphology | 1.74e-03 | 1033 | 25 | 7 | MP:0008251 | |
| MousePheno | reduced female fertility | 1.75e-03 | 296 | 25 | 4 | MP:0001923 | |
| Domain | Nicotinic_acetylcholine_rcpt | 5.31e-09 | 16 | 26 | 4 | IPR002394 | |
| Domain | - | 2.57e-08 | 23 | 26 | 4 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 2.57e-08 | 23 | 26 | 4 | IPR027361 | |
| Domain | Neurotransmitter_ion_chnl_CS | 4.23e-07 | 45 | 26 | 4 | IPR018000 | |
| Domain | Neur_chan_memb | 4.63e-07 | 46 | 26 | 4 | PF02932 | |
| Domain | Neur_chan_LBD | 5.05e-07 | 47 | 26 | 4 | PF02931 | |
| Domain | Neur_channel | 5.05e-07 | 47 | 26 | 4 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.05e-07 | 47 | 26 | 4 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 5.05e-07 | 47 | 26 | 4 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 5.05e-07 | 47 | 26 | 4 | PS00236 | |
| Domain | - | 5.05e-07 | 47 | 26 | 4 | 2.70.170.10 | |
| Domain | TRPV5/TRPV6 | 1.86e-06 | 2 | 26 | 2 | IPR008344 | |
| Domain | 7TM_GPCR_Srsx | 1.65e-05 | 112 | 26 | 4 | SM01381 | |
| Domain | Somatstn_rcpt | 1.86e-05 | 5 | 26 | 2 | IPR000586 | |
| Domain | TRP_channel | 1.02e-04 | 11 | 26 | 2 | IPR004729 | |
| Domain | GPCR_Rhodpsn_7TM | 2.59e-04 | 670 | 26 | 6 | IPR017452 | |
| Domain | 7tm_1 | 2.74e-04 | 677 | 26 | 6 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.92e-04 | 685 | 26 | 6 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.06e-04 | 691 | 26 | 6 | PS50262 | |
| Domain | GPCR_Rhodpsn | 3.09e-04 | 692 | 26 | 6 | IPR000276 | |
| Domain | Ion_trans_dom | 5.20e-04 | 114 | 26 | 3 | IPR005821 | |
| Domain | Ion_trans | 5.20e-04 | 114 | 26 | 3 | PF00520 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 2.52e-09 | 11 | 25 | 4 | M883 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 3.77e-09 | 12 | 25 | 4 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 7.61e-09 | 14 | 25 | 4 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.04e-08 | 15 | 25 | 4 | MM14704 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.41e-08 | 272 | 25 | 8 | M13380 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.72e-07 | 7 | 25 | 3 | MM15311 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 1.72e-07 | 7 | 25 | 3 | M27596 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.11e-07 | 9 | 25 | 3 | MM15313 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 4.11e-07 | 9 | 25 | 3 | M27597 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.07e-06 | 12 | 25 | 3 | M48008 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 4.69e-06 | 19 | 25 | 3 | M47793 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.90e-06 | 260 | 25 | 6 | M39397 | |
| Pathway | WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS | 7.59e-06 | 159 | 25 | 5 | M39373 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY | 3.01e-05 | 5 | 25 | 2 | M48978 | |
| Pathway | WP_SLEEP_REGULATION | 3.99e-05 | 38 | 25 | 3 | M39504 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 8.41e-05 | 430 | 25 | 6 | MM15160 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.12e-04 | 144 | 25 | 4 | MM14501 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.26e-04 | 463 | 25 | 6 | M507 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.50e-04 | 59 | 25 | 3 | MM15838 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.46e-04 | 330 | 25 | 5 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.57e-04 | 333 | 25 | 5 | MM14963 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 2.64e-04 | 335 | 25 | 5 | MM14503 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 4.32e-04 | 205 | 25 | 4 | M752 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.82e-04 | 211 | 25 | 4 | MM14502 | |
| Pathway | WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS | 6.21e-04 | 21 | 25 | 2 | M39343 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 6.74e-04 | 411 | 25 | 5 | M735 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.91e-04 | 99 | 25 | 3 | MM14910 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 7.59e-04 | 646 | 25 | 6 | MM14962 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.43e-04 | 106 | 25 | 3 | M27200 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.11e-03 | 28 | 25 | 2 | MM14943 | |
| Pathway | REACTOME_TRP_CHANNELS | 1.11e-03 | 28 | 25 | 2 | M27241 | |
| Pathway | WP_GPCRS_NONODORANT | 1.15e-03 | 266 | 25 | 4 | MM15843 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 1.17e-03 | 702 | 25 | 6 | M746 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.21e-03 | 270 | 25 | 4 | M15514 | |
| Pathway | WP_GPCRS_ODORANT | 2.60e-03 | 157 | 25 | 3 | MM15872 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.60e-03 | 176 | 25 | 3 | MM15718 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.01e-03 | 183 | 25 | 3 | M997 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 4.14e-03 | 185 | 25 | 3 | M39718 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.20e-03 | 186 | 25 | 3 | MM15994 | |
| Pathway | WP_GPCRS_PEPTIDE | 6.77e-03 | 70 | 25 | 2 | MM15959 | |
| Pathway | WP_PEPTIDE_GPCRS | 7.74e-03 | 75 | 25 | 2 | M39696 | |
| Pubmed | 2.87e-10 | 14 | 27 | 4 | 19059502 | ||
| Pubmed | 5.21e-10 | 16 | 27 | 4 | 19259974 | ||
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 1.11e-09 | 19 | 27 | 4 | 17373692 | |
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 1.39e-09 | 275 | 27 | 7 | 20734064 | |
| Pubmed | Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus. | 4.17e-09 | 5 | 27 | 3 | 12663058 | |
| Pubmed | 4.17e-09 | 5 | 27 | 3 | 25031416 | ||
| Pubmed | Low ethanol concentration alters CHRNA5 RNA levels during early human development. | 4.17e-09 | 5 | 27 | 3 | 20438829 | |
| Pubmed | Human alpha4beta2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: A patch-clamp study. | 4.17e-09 | 5 | 27 | 3 | 8987816 | |
| Pubmed | Changes in Nicotinic Neurotransmission during Enteric Nervous System Development. | 8.33e-09 | 6 | 27 | 3 | 25948261 | |
| Pubmed | α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion. | 8.33e-09 | 6 | 27 | 3 | 21485013 | |
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 8563774 | ||
| Pubmed | 1.46e-08 | 7 | 27 | 3 | 9009220 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 1.46e-08 | 7 | 27 | 3 | 1505988 | |
| Pubmed | 2.33e-08 | 8 | 27 | 3 | 17559419 | ||
| Pubmed | Functional interaction between Lypd6 and nicotinic acetylcholine receptors. | 2.33e-08 | 8 | 27 | 3 | 27344019 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 3.14e-08 | 118 | 27 | 5 | 19156168 | |
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 8906617 | ||
| Pubmed | 3.49e-08 | 9 | 27 | 3 | 19228980 | ||
| Pubmed | 4.99e-08 | 10 | 27 | 3 | 20736995 | ||
| Pubmed | Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. | 6.86e-08 | 11 | 27 | 3 | 29791835 | |
| Pubmed | 6.86e-08 | 11 | 27 | 3 | 12225896 | ||
| Pubmed | Analysis of nicotinic acetylcholine receptor subunits in the cochlea of the mouse. | 1.89e-07 | 15 | 27 | 3 | 8838678 | |
| Pubmed | MafB-dependent neurotransmitter signaling promotes β cell migration in the developing pancreas. | 2.82e-07 | 17 | 27 | 3 | 36897571 | |
| Pubmed | Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. | 5.80e-07 | 2 | 27 | 2 | 10235262 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27559543 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27698419 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19620239 | ||
| Pubmed | Extracellular domain nicotinic acetylcholine receptors formed by alpha4 and beta2 subunits. | 5.80e-07 | 2 | 27 | 2 | 16174636 | |
| Pubmed | Properties of mutated murine alpha4beta2 nicotinic receptors linked to partial epilepsy. | 5.80e-07 | 2 | 27 | 2 | 18321647 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20178461 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22354706 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 5.80e-07 | 2 | 27 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 5.80e-07 | 2 | 27 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 5.80e-07 | 2 | 27 | 2 | 23968883 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12681012 | ||
| Pubmed | The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs. | 5.80e-07 | 2 | 27 | 2 | 12871652 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12390878 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15569257 | ||
| Pubmed | α4β2 nicotinic acetylcholine receptors intrinsically influence body weight in mice. | 5.80e-07 | 2 | 27 | 2 | 31881170 | |
| Pubmed | An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors. | 5.80e-07 | 2 | 27 | 2 | 25869137 | |
| Pubmed | Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. | 5.80e-07 | 2 | 27 | 2 | 12574114 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 28446611 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26858154 | ||
| Pubmed | Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. | 5.80e-07 | 2 | 27 | 2 | 11549322 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19140341 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 10531434 | ||
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 5.80e-07 | 2 | 27 | 2 | 30916584 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 31130483 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21343288 | ||
| Pubmed | [Molecular and genetic basis of idiopathic nocturnal frontal lobe epilepsy]. | 5.80e-07 | 2 | 27 | 2 | 12185808 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25451094 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15154117 | ||
| Pubmed | Tonic nicotinic modulation of serotoninergic transmission in the spinal cord. | 5.80e-07 | 2 | 27 | 2 | 11226321 | |
| Pubmed | Association of alpha4beta2 nicotinic receptor and heavy smoking in schizophrenia. | 5.80e-07 | 2 | 27 | 2 | 18043764 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21451042 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16565876 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 22241831 | ||
| Pubmed | Variants in CHRNB2 and CHRNA4 Identified in Patients with Insular Epilepsy. | 5.80e-07 | 2 | 27 | 2 | 32536355 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26644472 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27895161 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30414940 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 26269589 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 29074617 | ||
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 5.80e-07 | 2 | 27 | 2 | 16705151 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 18095155 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23056257 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 16636791 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17226798 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15537871 | ||
| Pubmed | Roles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality. | 5.80e-07 | 2 | 27 | 2 | 27986975 | |
| Pubmed | Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density. | 5.80e-07 | 2 | 27 | 2 | 23429692 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24850280 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 20405023 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 18762859 | ||
| Pubmed | Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR. | 5.80e-07 | 2 | 27 | 2 | 11261808 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 23734673 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 30176987 | ||
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 5.80e-07 | 2 | 27 | 2 | 11846401 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 25164318 | ||
| Pubmed | Structural principles of distinct assemblies of the human α4β2 nicotinic receptor. | 5.80e-07 | 2 | 27 | 2 | 29720657 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 15741168 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21252231 | ||
| Pubmed | NMR resolved multiple anesthetic binding sites in the TM domains of the α4β2 nAChR. | 5.80e-07 | 2 | 27 | 2 | 23000369 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 21768117 | ||
| Pubmed | Nicotine upregulates its own receptors through enhanced intracellular maturation. | 5.80e-07 | 2 | 27 | 2 | 15944128 | |
| Pubmed | The fifth subunit of the (α4β2)2 β2 nicotinic ACh receptor modulates maximal ACh responses. | 5.80e-07 | 2 | 27 | 2 | 28600847 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24761864 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 19101612 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12372020 | ||
| Pubmed | Regulation of the mouse epithelial Ca2(+) channel TRPV6 by the Ca(2+)-sensor calmodulin. | 5.80e-07 | 2 | 27 | 2 | 15123711 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 27793780 | ||
| Pubmed | Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors. | 5.80e-07 | 2 | 27 | 2 | 23399696 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 12077127 | ||
| Pubmed | Binding interactions with the complementary subunit of nicotinic receptors. | 5.80e-07 | 2 | 27 | 2 | 23349463 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24422997 | ||
| Pubmed | Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. | 5.80e-07 | 2 | 27 | 2 | 16023355 | |
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 17385675 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 11344259 | ||
| Pubmed | 5.80e-07 | 2 | 27 | 2 | 24982426 | ||
| Pubmed | The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open. | 5.80e-07 | 2 | 27 | 2 | 20649589 | |
| Interaction | CHRNA2 interactions | 4.80e-06 | 3 | 26 | 2 | int:CHRNA2 | |
| Interaction | LEMD2 interactions | 6.13e-06 | 94 | 26 | 4 | int:LEMD2 | |
| Interaction | C1QL1 interactions | 1.56e-05 | 38 | 26 | 3 | int:C1QL1 | |
| Interaction | TMEM39B interactions | 1.69e-05 | 39 | 26 | 3 | int:TMEM39B | |
| Interaction | TPST2 interactions | 1.84e-05 | 124 | 26 | 4 | int:TPST2 | |
| Interaction | DPY19L4 interactions | 2.27e-05 | 43 | 26 | 3 | int:DPY19L4 | |
| Interaction | ICAM4 interactions | 2.79e-05 | 46 | 26 | 3 | int:ICAM4 | |
| Interaction | TMEM39A interactions | 3.38e-05 | 49 | 26 | 3 | int:TMEM39A | |
| Interaction | DIPK2A interactions | 3.81e-05 | 51 | 26 | 3 | int:DIPK2A | |
| Interaction | COX18 interactions | 4.46e-05 | 8 | 26 | 2 | int:COX18 | |
| Interaction | HS6ST2 interactions | 4.53e-05 | 54 | 26 | 3 | int:HS6ST2 | |
| Interaction | RNF185 interactions | 4.75e-05 | 158 | 26 | 4 | int:RNF185 | |
| Interaction | CHRNA5 interactions | 4.78e-05 | 55 | 26 | 3 | int:CHRNA5 | |
| Interaction | NETO2 interactions | 4.78e-05 | 55 | 26 | 3 | int:NETO2 | |
| Interaction | SST interactions | 5.73e-05 | 9 | 26 | 2 | int:SST | |
| Interaction | GRAMD1A interactions | 6.04e-05 | 168 | 26 | 4 | int:GRAMD1A | |
| Interaction | TUSC3 interactions | 6.53e-05 | 61 | 26 | 3 | int:TUSC3 | |
| Interaction | GP1BB interactions | 7.19e-05 | 63 | 26 | 3 | int:GP1BB | |
| Interaction | ABHD14A interactions | 8.26e-05 | 66 | 26 | 3 | int:ABHD14A | |
| Interaction | TMUB1 interactions | 1.07e-04 | 72 | 26 | 3 | int:TMUB1 | |
| Interaction | DNAJC18 interactions | 1.21e-04 | 75 | 26 | 3 | int:DNAJC18 | |
| Interaction | TMEM237 interactions | 1.23e-04 | 202 | 26 | 4 | int:TMEM237 | |
| Interaction | ALG9 interactions | 1.31e-04 | 77 | 26 | 3 | int:ALG9 | |
| Interaction | JKAMP interactions | 1.44e-04 | 14 | 26 | 2 | int:JKAMP | |
| Interaction | POMGNT2 interactions | 1.58e-04 | 82 | 26 | 3 | int:POMGNT2 | |
| Interaction | CISD2 interactions | 2.13e-04 | 233 | 26 | 4 | int:CISD2 | |
| Interaction | SPPL2B interactions | 2.13e-04 | 233 | 26 | 4 | int:SPPL2B | |
| Interaction | RHCG interactions | 2.15e-04 | 17 | 26 | 2 | int:RHCG | |
| Interaction | CALB1 interactions | 2.42e-04 | 18 | 26 | 2 | int:CALB1 | |
| Interaction | TMTC3 interactions | 2.84e-04 | 100 | 26 | 3 | int:TMTC3 | |
| Interaction | TMEM87B interactions | 3.00e-04 | 20 | 26 | 2 | int:TMEM87B | |
| Interaction | UGT3A2 interactions | 3.00e-04 | 20 | 26 | 2 | int:UGT3A2 | |
| Interaction | SLC44A5 interactions | 3.31e-04 | 21 | 26 | 2 | int:SLC44A5 | |
| Interaction | CORT interactions | 3.31e-04 | 21 | 26 | 2 | int:CORT | |
| Interaction | FLG interactions | 3.46e-04 | 107 | 26 | 3 | int:FLG | |
| Interaction | GABRB3 interactions | 3.64e-04 | 22 | 26 | 2 | int:GABRB3 | |
| Interaction | TRHR interactions | 3.64e-04 | 22 | 26 | 2 | int:TRHR | |
| Interaction | PIGB interactions | 3.64e-04 | 22 | 26 | 2 | int:PIGB | |
| Interaction | FLG2 interactions | 3.96e-04 | 112 | 26 | 3 | int:FLG2 | |
| Interaction | LMF2 interactions | 4.50e-04 | 117 | 26 | 3 | int:LMF2 | |
| Interaction | ST3GAL6 interactions | 4.71e-04 | 25 | 26 | 2 | int:ST3GAL6 | |
| Interaction | RGPD2 interactions | 5.51e-04 | 27 | 26 | 2 | int:RGPD2 | |
| Interaction | CYB5R1 interactions | 5.72e-04 | 127 | 26 | 3 | int:CYB5R1 | |
| Interaction | HMOX1 interactions | 6.12e-04 | 130 | 26 | 3 | int:HMOX1 | |
| Interaction | GLT8D2 interactions | 6.36e-04 | 29 | 26 | 2 | int:GLT8D2 | |
| Interaction | PGAP1 interactions | 6.81e-04 | 30 | 26 | 2 | int:PGAP1 | |
| Interaction | ST6GALNAC3 interactions | 6.81e-04 | 30 | 26 | 2 | int:ST6GALNAC3 | |
| Interaction | SLC25A24 interactions | 6.83e-04 | 135 | 26 | 3 | int:SLC25A24 | |
| Interaction | SIDT2 interactions | 7.59e-04 | 140 | 26 | 3 | int:SIDT2 | |
| Interaction | C6orf120 interactions | 7.75e-04 | 32 | 26 | 2 | int:C6orf120 | |
| Interaction | FUT8 interactions | 7.91e-04 | 142 | 26 | 3 | int:FUT8 | |
| Interaction | GOLM1 interactions | 8.40e-04 | 145 | 26 | 3 | int:GOLM1 | |
| Interaction | TMEM131 interactions | 8.40e-04 | 145 | 26 | 3 | int:TMEM131 | |
| Interaction | ERMP1 interactions | 8.74e-04 | 147 | 26 | 3 | int:ERMP1 | |
| Interaction | ASPHD2 interactions | 8.75e-04 | 34 | 26 | 2 | int:ASPHD2 | |
| Interaction | ABCC10 interactions | 9.81e-04 | 36 | 26 | 2 | int:ABCC10 | |
| Interaction | ZW10 interactions | 1.02e-03 | 155 | 26 | 3 | int:ZW10 | |
| Interaction | EIF2AK3 interactions | 1.02e-03 | 155 | 26 | 3 | int:EIF2AK3 | |
| Interaction | CASP14 interactions | 1.04e-03 | 156 | 26 | 3 | int:CASP14 | |
| Interaction | TGM3 interactions | 1.08e-03 | 158 | 26 | 3 | int:TGM3 | |
| Interaction | SEMA4F interactions | 1.09e-03 | 38 | 26 | 2 | int:SEMA4F | |
| Interaction | CHRNA4 interactions | 1.10e-03 | 159 | 26 | 3 | int:CHRNA4 | |
| Interaction | CHRNA3 interactions | 1.15e-03 | 39 | 26 | 2 | int:CHRNA3 | |
| Interaction | MS4A3 interactions | 1.21e-03 | 40 | 26 | 2 | int:MS4A3 | |
| Interaction | GLRB interactions | 1.27e-03 | 41 | 26 | 2 | int:GLRB | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q34 | 1.75e-04 | 185 | 27 | 3 | chr7q34 | |
| Cytoband | 11p15 | 2.96e-04 | 43 | 27 | 2 | 11p15 | |
| Cytoband | 7q35 | 4.85e-04 | 55 | 27 | 2 | 7q35 | |
| Cytoband | 2q11.2 | 8.30e-04 | 72 | 27 | 2 | 2q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 3.67e-03 | 153 | 27 | 2 | chr2q11 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 5.12e-09 | 16 | 25 | 4 | 173 | |
| GeneFamily | Somatostatin receptors | 1.83e-05 | 5 | 25 | 2 | 257 | |
| GeneFamily | Transient receptor potential cation channels | 6.79e-04 | 28 | 25 | 2 | 249 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CHST10 EFNA5 CLCN1 HTR2A SSTR2 SSTR4 CHRNA4 CHRNB2 CFTR UGCG | 2.95e-07 | 1281 | 27 | 10 | M1884 |
| Coexpression | GSE15215_CD2_POS_VS_NEG_PDC_UP | 4.56e-05 | 195 | 27 | 4 | M3519 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.62e-06 | 175 | 27 | 4 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 184 | 27 | 4 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-06 | 184 | 27 | 4 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.17e-05 | 140 | 27 | 3 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | TCGA-Peripheral_Nervous_System|World / Sample_Type by Project: Shred V9 | 8.88e-05 | 144 | 27 | 3 | 3bbadb4b07ffb461d5400a5d69ad3b259f74041e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.06e-05 | 145 | 27 | 3 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-4|TCGA-Brain / Sample_Type by Project: Shred V9 | 9.25e-05 | 146 | 27 | 3 | 632f52780607c638b5d3dd3fb9251c719f162a35 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 153 | 27 | 3 | 0727dc70e16345645063c586d744bc4ac1710526 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 154 | 27 | 3 | 9316732964a819a8e935a952faa3823109f90b77 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 157 | 27 | 3 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 157 | 27 | 3 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 157 | 27 | 3 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 158 | 27 | 3 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 160 | 27 | 3 | fe5fb0e7a79862f63529721f0a82f4f6d231d3ca | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.21e-04 | 160 | 27 | 3 | 7d34159363d274019e14549d1186c629ce990691 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.24e-04 | 161 | 27 | 3 | 5f6b2d7f80a8ee16651e304481d2da3fae313824 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.24e-04 | 161 | 27 | 3 | 0605134a342d74ae81f33700d6ddfcd6e03aeb7b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-04 | 162 | 27 | 3 | 58da6bc04cdac0002b0e6a751c96ff95e1a7f70f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 166 | 27 | 3 | 548d0d6c0ffd564036ddba78620734220ebb73d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 166 | 27 | 3 | 80e164a89d22098cabe4a99a78283ba69ea0561e | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.38e-04 | 167 | 27 | 3 | 7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 167 | 27 | 3 | edc5f04584b44f99ff9a62bbe0dab6fc044fb334 | |
| ToppCell | droplet-Lung-30m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.43e-04 | 169 | 27 | 3 | 1de3ae36d3b60e961bfd9f7bdc37867b82a0417f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 171 | 27 | 3 | 99176a932569fa1c7e1c01009684f5a65244b96e | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.69e-04 | 179 | 27 | 3 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 179 | 27 | 3 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 180 | 27 | 3 | 2b6b295b5c21b829828afae9ab4c3eb9233f6f45 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 180 | 27 | 3 | bf587387145a2b5e83766fbccf76eecc6d5e8241 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-04 | 180 | 27 | 3 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-04 | 180 | 27 | 3 | 5286e66ff6b7154390b3e9c189704a71d56bc89c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.80e-04 | 183 | 27 | 3 | 7e2bac8b005155888ff4b41ef2e1d975dc17abc7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 184 | 27 | 3 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 185 | 27 | 3 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-04 | 186 | 27 | 3 | d65fa6d8e8a195ea10cfde1499d096d6acf7a634 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 186 | 27 | 3 | 18fd311252299d6d30ddb32002ed069056108206 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-04 | 186 | 27 | 3 | 15f2e5905486e33f6f7b3b3e9758a0559e8c61ee | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.89e-04 | 186 | 27 | 3 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 187 | 27 | 3 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-04 | 188 | 27 | 3 | 4154f4787483c7e076e87a187733a9f666742c3d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.95e-04 | 188 | 27 | 3 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 189 | 27 | 3 | 8ff3c3232eff9de4b5c9b22ecb82bc509d773f58 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 189 | 27 | 3 | 90aae7e806882bebfad78a78e9a16cf56af3ecd4 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.01e-04 | 190 | 27 | 3 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 190 | 27 | 3 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | background-Cholangiocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.04e-04 | 191 | 27 | 3 | 99aa8d685767a72bef9f05e7cc8913126a048c39 | |
| ToppCell | 11.5-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 2.08e-04 | 192 | 27 | 3 | a77d3692ff02ef7e066a9bd9e22725055a25c4d4 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CFuPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 192 | 27 | 3 | a8841ebd879f1c344ab4246fdef77044170f644d | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 192 | 27 | 3 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 2.08e-04 | 192 | 27 | 3 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 461919ab422bc9d1fcff7a3a4757c75239041d7e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 193 | 27 | 3 | 0dd810ad900d3e586551622b2c1de39d76fd6a7f | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.17e-04 | 195 | 27 | 3 | 9c9634906168239cf978adb398787692437bf9e7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 195 | 27 | 3 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.17e-04 | 195 | 27 | 3 | 574354ef4bcefeb9856b65d19bb92e2cffe5dc7a | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.17e-04 | 195 | 27 | 3 | d87c83d2d421c9291d0a10bc9db850e9fb337667 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 2.24e-04 | 197 | 27 | 3 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 2.24e-04 | 197 | 27 | 3 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| Computational | Membranal receptors. | 4.48e-06 | 517 | 16 | 7 | MODULE_64 | |
| Computational | Ion channels. | 7.74e-06 | 27 | 16 | 3 | MODULE_214 | |
| Computational | Genes in the cancer module 146. | 1.27e-05 | 102 | 16 | 4 | MODULE_146 | |
| Computational | Genes in the cancer module 267. | 2.16e-04 | 15 | 16 | 2 | MODULE_267 | |
| Computational | Vesicular transport / synapse genes. | 2.23e-04 | 82 | 16 | 3 | MODULE_274 | |
| Computational | Genes in the cancer module 27. | 1.55e-03 | 355 | 16 | 4 | MODULE_27 | |
| Drug | Anabasine | 5.94e-09 | 4 | 27 | 3 | ctd:D000691 | |
| Drug | 2-(1'-methyl-2'-pyrrolidinyl)-7-hydroxy-1,4-benzodioxane | 5.94e-09 | 4 | 27 | 3 | ctd:C569671 | |
| Drug | N-(1,2,3,4-tetrahydro-1-naphthyl)-4-nitroaniline | 1.48e-08 | 5 | 27 | 3 | ctd:C524978 | |
| Drug | cisatracurium | 1.48e-08 | 5 | 27 | 3 | ctd:C101584 | |
| Drug | decamethonium | 2.97e-08 | 6 | 27 | 3 | ctd:C033019 | |
| Drug | Nicotine | 2.97e-08 | 6 | 27 | 3 | DB00184 | |
| Drug | mivacurium | 5.19e-08 | 7 | 27 | 3 | ctd:C049430 | |
| Drug | EPTC | 5.19e-08 | 7 | 27 | 3 | ctd:C036251 | |
| Drug | Atracurium | 5.19e-08 | 7 | 27 | 3 | ctd:D001279 | |
| Drug | gamma-aminobutyric acid | 5.22e-08 | 474 | 27 | 8 | CID000000119 | |
| Drug | methyllycaconitine | 6.27e-08 | 33 | 27 | 4 | ctd:C054634 | |
| Drug | Dimethylphenylpiperazinium Iodide | 8.30e-08 | 8 | 27 | 3 | ctd:D004246 | |
| Drug | epibatidine | 8.30e-08 | 8 | 27 | 3 | ctd:C082748 | |
| Drug | Galantamine | 8.30e-08 | 8 | 27 | 3 | DB00674 | |
| Drug | ivermectin | 1.16e-07 | 101 | 27 | 5 | CID006435110 | |
| Drug | fenoxycarb | 1.24e-07 | 9 | 27 | 3 | ctd:C052034 | |
| Drug | oxotremorine | 1.63e-07 | 108 | 27 | 5 | CID000004630 | |
| Drug | gallamin | 1.87e-07 | 43 | 27 | 4 | CID000067425 | |
| Drug | cytisine | 2.44e-07 | 11 | 27 | 3 | ctd:C004712 | |
| Drug | Pancuronium | 2.44e-07 | 11 | 27 | 3 | ctd:D010197 | |
| Drug | Dihydro-beta-Erythroidine | 2.44e-07 | 11 | 27 | 3 | ctd:D004079 | |
| Drug | rocuronium | 2.44e-07 | 11 | 27 | 3 | ctd:C061870 | |
| Drug | neuroNal | 3.20e-07 | 49 | 27 | 4 | CID000010535 | |
| Drug | Vecuronium Bromide | 3.25e-07 | 12 | 27 | 3 | ctd:D014673 | |
| Drug | 1-phenylethanol | 3.77e-07 | 51 | 27 | 4 | CID000007409 | |
| Drug | tetramethylammonium | 4.41e-07 | 53 | 27 | 4 | CID000006380 | |
| Drug | donepezil | 4.41e-07 | 53 | 27 | 4 | CID000003152 | |
| Drug | AC1Q3ZOL | 4.84e-07 | 258 | 27 | 6 | CID000002376 | |
| Drug | Varenicline | 5.37e-07 | 14 | 27 | 3 | ctd:D000068580 | |
| Drug | benzodiazepine | 6.36e-07 | 142 | 27 | 5 | CID000134664 | |
| Drug | (-)-pictamine | 6.70e-07 | 15 | 27 | 3 | CID006918623 | |
| Drug | (-)-lepadin B | 6.70e-07 | 15 | 27 | 3 | CID006918624 | |
| Drug | UB-165 | 6.70e-07 | 15 | 27 | 3 | CID004694339 | |
| Drug | Hexamethonium | 8.24e-07 | 16 | 27 | 3 | ctd:D018738 | |
| Drug | AC1L2SVN | 8.24e-07 | 16 | 27 | 3 | CID000127922 | |
| Drug | benzoquinonium | 8.24e-07 | 16 | 27 | 3 | CID000009393 | |
| Drug | procaine | 9.19e-07 | 153 | 27 | 5 | CID000004914 | |
| Drug | Carbaryl | 9.49e-07 | 64 | 27 | 4 | ctd:D012721 | |
| Drug | Ultracet | 9.49e-07 | 64 | 27 | 4 | CID000005523 | |
| Drug | ABT-594 | 1.20e-06 | 18 | 27 | 3 | CID003075702 | |
| Drug | AC1LCVGE | 1.20e-06 | 18 | 27 | 3 | CID000656712 | |
| Drug | verapamil | 1.25e-06 | 490 | 27 | 7 | CID000002520 | |
| Drug | 17alpha-estradiol | CMKLR1 EFNA5 CLCN1 HTR2A SSTR2 CHRNA9 CHRNA4 CHRNB2 CFTR UGCG | 1.25e-06 | 1303 | 27 | 10 | CID000000450 |
| Drug | subecholine | 1.35e-06 | 2 | 27 | 2 | ctd:C009335 | |
| Drug | 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole | 1.35e-06 | 2 | 27 | 2 | ctd:C088383 | |
| Drug | ispronicline | 1.35e-06 | 2 | 27 | 2 | ctd:C490152 | |
| Drug | 5-(2-azetidinylmethoxy)-2-chloropyridine | 1.35e-06 | 2 | 27 | 2 | ctd:C109763 | |
| Drug | metanicotine | 1.35e-06 | 2 | 27 | 2 | ctd:C012419 | |
| Drug | 3-(2-(pyrrolidinyl)methoxy)pyridine | 1.35e-06 | 2 | 27 | 2 | ctd:C116733 | |
| Drug | Bridged Bicyclo Compounds, Heterocyclic | 1.35e-06 | 2 | 27 | 2 | ctd:D019086 | |
| Drug | TC 2559 | 1.35e-06 | 2 | 27 | 2 | ctd:C419442 | |
| Drug | Fire Trol 934 | 1.35e-06 | 2 | 27 | 2 | ctd:C508049 | |
| Drug | 1-Butanol | 1.36e-06 | 70 | 27 | 4 | ctd:D020001 | |
| Drug | AC1L9P88 | 1.42e-06 | 19 | 27 | 3 | CID000450860 | |
| Drug | isoarecolone | 1.42e-06 | 19 | 27 | 3 | CID000146970 | |
| Drug | beta-erythroidine | 1.42e-06 | 19 | 27 | 3 | CID000010074 | |
| Drug | perhydrohistrionicotoxin | 1.42e-06 | 19 | 27 | 3 | CID000107881 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.42e-06 | 19 | 27 | 3 | CID000162425 | |
| Drug | potassium | 1.44e-06 | 1008 | 27 | 9 | CID000000813 | |
| Drug | forskolin from Coleus forskohlii | 1.50e-06 | 1013 | 27 | 9 | CID000003413 | |
| Drug | Barium | 1.53e-06 | 72 | 27 | 4 | ctd:D001464 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.67e-06 | 20 | 27 | 3 | CID000001962 | |
| Drug | dinotefuran | 1.95e-06 | 21 | 27 | 3 | CID000197701 | |
| Drug | meproadifen | 1.95e-06 | 21 | 27 | 3 | CID000189752 | |
| Drug | iodide | 2.22e-06 | 534 | 27 | 7 | CID000024841 | |
| Drug | AR-R17779 | 2.26e-06 | 22 | 27 | 3 | CID005310971 | |
| Drug | histrionicotoxin | 2.26e-06 | 22 | 27 | 3 | CID005282247 | |
| Drug | clothianidin | 2.26e-06 | 22 | 27 | 3 | CID000213027 | |
| Drug | trimethaphan | 2.45e-06 | 81 | 27 | 4 | CID000023576 | |
| Drug | Substance P | 2.54e-06 | 343 | 27 | 6 | CID000036511 | |
| Drug | AC1L3BL8 | 2.59e-06 | 23 | 27 | 3 | CID000086457 | |
| Drug | alpha-conotoxin ImI | 2.59e-06 | 23 | 27 | 3 | CID000133011 | |
| Drug | CID6325740 | 2.59e-06 | 23 | 27 | 3 | CID006325740 | |
| Drug | ABT-418 | 2.59e-06 | 23 | 27 | 3 | CID000119380 | |
| Drug | alpha-conotoxin SI | 2.59e-06 | 23 | 27 | 3 | CID000163979 | |
| Drug | Skpymrfamide | 2.59e-06 | 23 | 27 | 3 | CID000132661 | |
| Drug | vinblastine | 2.60e-06 | 189 | 27 | 5 | CID000013342 | |
| Drug | serotonin | 2.83e-06 | 554 | 27 | 7 | CID000005202 | |
| Drug | metoclopramide | 2.84e-06 | 84 | 27 | 4 | CID000004168 | |
| Drug | LS-63783 | 2.85e-06 | 804 | 27 | 8 | CID000000231 | |
| Drug | procyclidine | 2.96e-06 | 24 | 27 | 3 | CID000004919 | |
| Drug | intruder | 2.96e-06 | 24 | 27 | 3 | CID000213021 | |
| Drug | anabaseine | 2.96e-06 | 24 | 27 | 3 | CID000018985 | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 3.03e-06 | 195 | 27 | 5 | 4424_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.19e-06 | 197 | 27 | 5 | 5703_UP | |
| Drug | anabasine | 3.36e-06 | 25 | 27 | 3 | CID000002181 | |
| Drug | varenicline | 3.36e-06 | 25 | 27 | 3 | CID000170361 | |
| Drug | pempidine | 3.36e-06 | 25 | 27 | 3 | CID000006603 | |
| Drug | bethanechol | 3.74e-06 | 90 | 27 | 4 | CID000002370 | |
| Drug | benzquinamide | 3.80e-06 | 26 | 27 | 3 | CID000002342 | |
| Drug | 1kwq | 3.80e-06 | 26 | 27 | 3 | CID003092847 | |
| Drug | AC1O0V2G | 3.80e-06 | 26 | 27 | 3 | CID006102809 | |
| Drug | beta-eudesmol | 3.80e-06 | 26 | 27 | 3 | CID000091457 | |
| Drug | curarine | 3.80e-06 | 26 | 27 | 3 | CID000198004 | |
| Drug | Acetylcholine | 3.91e-06 | 91 | 27 | 4 | ctd:D000109 | |
| Drug | ponceau 4R | 4.06e-06 | 3 | 27 | 2 | ctd:C576297 | |
| Drug | 13,19-didesmethyl spirolide C | 4.06e-06 | 3 | 27 | 2 | ctd:C544516 | |
| Drug | sazetidine-A | 4.06e-06 | 3 | 27 | 2 | ctd:C514816 | |
| Drug | Alcuronium | 4.06e-06 | 3 | 27 | 2 | ctd:D000443 | |
| Drug | A 85380 | 4.06e-06 | 3 | 27 | 2 | ctd:C104288 | |
| Disease | Frontal Epilepsy, Benign, Childhood | 4.47e-06 | 4 | 26 | 2 | C0393671 | |
| Disease | Epilepsy, Cingulate | 4.47e-06 | 4 | 26 | 2 | C0393684 | |
| Disease | Epilepsy, Supplementary Motor | 4.47e-06 | 4 | 26 | 2 | C0393683 | |
| Disease | Epilepsy, Opercular | 4.47e-06 | 4 | 26 | 2 | C0393688 | |
| Disease | Epilepsy, Orbito-Frontal | 4.47e-06 | 4 | 26 | 2 | C0751643 | |
| Disease | Epilepsy, Anterior Fronto-Polar | 4.47e-06 | 4 | 26 | 2 | C0751642 | |
| Disease | Epilepsy, Frontal Lobe | 4.47e-06 | 4 | 26 | 2 | C0085541 | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 4.47e-06 | 4 | 26 | 2 | cv:C3696898 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 1.56e-05 | 7 | 26 | 2 | C3696898 | |
| Disease | Subwakefullness Syndrome | 1.56e-05 | 7 | 26 | 2 | C0751511 | |
| Disease | Sleep-Related Neurogenic Tachypnea | 1.56e-05 | 7 | 26 | 2 | C0751510 | |
| Disease | Short Sleeper Syndrome | 1.56e-05 | 7 | 26 | 2 | C0751509 | |
| Disease | Long Sleeper Syndrome | 1.56e-05 | 7 | 26 | 2 | C0751508 | |
| Disease | Sleep Disorders | 1.56e-05 | 7 | 26 | 2 | C0851578 | |
| Disease | Sleep Wake Disorders | 1.56e-05 | 7 | 26 | 2 | C4042891 | |
| Disease | Metabolic Diseases | 3.35e-05 | 10 | 26 | 2 | C0025517 | |
| Disease | nicotine dependence | 4.42e-05 | 78 | 26 | 3 | EFO_0003768 | |
| Disease | Alcoholic Intoxication, Chronic | 8.50e-05 | 268 | 26 | 4 | C0001973 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 8.89e-05 | 16 | 26 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | Visual seizure | 9.56e-05 | 101 | 26 | 3 | C0270824 | |
| Disease | Epileptic drop attack | 9.56e-05 | 101 | 26 | 3 | C0270846 | |
| Disease | Generalized seizures | 9.56e-05 | 101 | 26 | 3 | C0234533 | |
| Disease | Clonic Seizures | 9.56e-05 | 101 | 26 | 3 | C0234535 | |
| Disease | Vertiginous seizure | 9.56e-05 | 101 | 26 | 3 | C0422855 | |
| Disease | Gustatory seizure | 9.56e-05 | 101 | 26 | 3 | C0422854 | |
| Disease | Seizures, Somatosensory | 9.56e-05 | 101 | 26 | 3 | C0422850 | |
| Disease | Olfactory seizure | 9.56e-05 | 101 | 26 | 3 | C0422853 | |
| Disease | Seizures, Auditory | 9.56e-05 | 101 | 26 | 3 | C0422852 | |
| Disease | Generalized Absence Seizures | 9.56e-05 | 101 | 26 | 3 | C4505436 | |
| Disease | Convulsive Seizures | 9.56e-05 | 101 | 26 | 3 | C0751494 | |
| Disease | Seizures, Sensory | 9.56e-05 | 101 | 26 | 3 | C0751496 | |
| Disease | Atonic Absence Seizures | 9.56e-05 | 101 | 26 | 3 | C0751123 | |
| Disease | Complex partial seizures | 9.56e-05 | 101 | 26 | 3 | C0149958 | |
| Disease | Single Seizure | 9.56e-05 | 101 | 26 | 3 | C0751110 | |
| Disease | Epileptic Seizures | 9.56e-05 | 101 | 26 | 3 | C4317109 | |
| Disease | Jacksonian Seizure | 9.56e-05 | 101 | 26 | 3 | C0022333 | |
| Disease | Non-epileptic convulsion | 9.56e-05 | 101 | 26 | 3 | C0751056 | |
| Disease | Nonepileptic Seizures | 9.56e-05 | 101 | 26 | 3 | C3495874 | |
| Disease | Tonic Seizures | 9.84e-05 | 102 | 26 | 3 | C0270844 | |
| Disease | Absence Seizures | 9.84e-05 | 102 | 26 | 3 | C4316903 | |
| Disease | Convulsions | 9.84e-05 | 102 | 26 | 3 | C4048158 | |
| Disease | Seizures, Focal | 1.04e-04 | 104 | 26 | 3 | C0751495 | |
| Disease | Myoclonic Seizures | 1.04e-04 | 104 | 26 | 3 | C4317123 | |
| Disease | Tonic - clonic seizures | 1.04e-04 | 104 | 26 | 3 | C0494475 | |
| Disease | energy expenditure measurement | 1.40e-04 | 20 | 26 | 2 | EFO_0008005 | |
| Disease | Minimal Brain Dysfunction | 1.71e-04 | 22 | 26 | 2 | C1321905 | |
| Disease | Attention Deficit Disorder | 1.71e-04 | 22 | 26 | 2 | C0041671 | |
| Disease | Attention deficit hyperactivity disorder | 2.04e-04 | 24 | 26 | 2 | C1263846 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 2.78e-04 | 28 | 26 | 2 | DOID:1094 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MVVDRLFLWVFMFVC | 456 | P30926 | |
| MVIDRIFLWMFIIVC | 596 | P43681 | |
| LRWFQMRIEMIFVIF | 1096 | P13569 | |
| LFVVMWCPFFITNIM | 331 | P28223 | |
| WIFFIMVFVMTILII | 461 | Q9UGM1 | |
| VMRMLAVILLVVFWF | 526 | Q5T848 | |
| LTMFVVFVIFAICWA | 251 | P49286 | |
| MDWSFFRVVAMLFIF | 1 | Q02413 | |
| VCVVWFTFEFLMRVI | 251 | P48547 | |
| MSRAMALFFVLCWIQ | 1 | A0A1B0GVN3 | |
| FRWDIMVFFMCHCLA | 311 | Q16739 | |
| MVFFMCHCLAWFIFD | 316 | Q16739 | |
| MLTLVFLVLWMCVFS | 6 | P52803 | |
| RAVMLMISIWIFSFF | 156 | Q99680 | |
| MLQMFRELTAVRCYW | 286 | Q9BYJ4 | |
| VLMVVVVFVLCWMPF | 261 | P31391 | |
| WMFRIRIILCLMGAF | 196 | Q96K19 | |
| RMVSIVVAVFIFCWL | 256 | P30874 | |
| MVIDRLFLWIFVFVC | 456 | P17787 | |
| FWMLVEAVILFLMVR | 681 | Q14246 | |
| AYMACMVIWVLAFFL | 156 | Q99788 | |
| LLLAACFWVIFMFMV | 6 | O43529 | |
| CFWVIFMFMVASKFI | 11 | O43529 | |
| VVIIIFLFFVMKFWM | 456 | P35523 | |
| FMVRLFVVIVMFAWS | 181 | Q96EC8 | |
| WMIVIHFFLVNVFVM | 21 | O15374 | |
| IFGDLMRFCWLMAVV | 526 | Q9H1D0 | |
| MRFCWLMAVVILGFA | 531 | Q9H1D0 | |
| WLGMVVCRFLEMRTY | 231 | P48651 | |
| IFGDLMRFCWLMAVV | 486 | Q9NQA5 | |
| MRFCWLMAVVILGFA | 491 | Q9NQA5 |